Worth Switching

Infection rates don't have to be high for Cook Spectrum to be a smart choice for your facility. CLABSIs/CRBSIs are among the most expensive HAIs per case,⁴ so even incremental reductions in CLABSIs/CRBSIs can create significant savings. By switching to Spectrum, even high-performing hospitals with low infection rates can achieve substantial reductions in mortalities and cost that are associated with infections.

Plus, by reducing your CRBSI rate, Spectrum technology can help your hospital lower the risk for a Hospital-Acquired Condition (HAC) Reduction Program score that triggers a 1% reduction in inpatient Medicare reimbursement.
Learn more about HAC score penalties.

Consider a facility that places 100 CVCs per month, using these numbers from the CDC³ and from recent studies ^{1, 2} that detail the toll of CRBSIs:

Acute CVCs

CVCs Placed Per Month Enter the amount of CVCs placed per month. Enter digits 0-9 only. Max 3 digits total, no decimal places.	CVCs Placed Annually	Annual Catheter Days
	1200	8400
	Average Dwell Time
	7 DAYS citing 1


Infection Rate Per 1000 Catheter Days Enter the average infection rate per 1000 catheter days. Enter digits 0-9, 1 decimal place allowed.	Total CRBSIs Annually	Average Excess Length of Stay
	28	8 DAYS citing 6
	Average Cost to Treat CRBSI	Cost to Treat CRBSIs Annually
	$45,814.00 citing 3	$463,400.00
Reset Fields
	Bed Days Spent to Treat CRBSIs
	224



Based on your entries on the previous table, the impact of a 50% reduction in the CRBSI rate is shown below.
Infection Rate Per 1000 Catheter Days	Total CRBSIs	Average Dollars Saved Per Catheter
1.65	14	$193.08
Average Time Saved Per Catheter	Dollars Saved Annually	Bed Days Saved Annually
2 Hrs, 14 Min	$231,700.00	112

The calculations presented here show a modest change in infection rates and associated costs. However, the ultimate goal of any infection prevention program should be to strive for

zero.

With Spectrum plus your process bundle, we can help you reach for that goal.

References – Worth Switching

Ramos ER, Reitzel R, Jiang Y, et al. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011;39(2):245-251.
Advani S, Reich NG, Sengupta A, et al. Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis. 2011;52(9):1108-1115.
Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046. The $45,814 figure stated in the above calculator is the average between $30,919-$65,245, as referenced in this article.
Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system [published online ahead of print September 2, 2013]. JAMA Intern Med. 2013;2. doi:10.1001/jamainternmed.2013.9763.
Srinivasan A, Wise M, Bell M, et al. Vital signs: central line-associated blood stream infections — United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011;60(8):243-248.
Warren DK, Quadir WW, Hollenbeak CS, et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34(8):2084–2089.